Tag: Manaus variant
RIO DE JANEIRO, BRAZIL - Preliminary results of a research conducted by the Vebra Covid-19 group released on Wednesday, March 7, pointed out that CoronaVac - the most used vaccine in Brazil today - is 50% effective against symptomatic...
RIO DE JANEIRO, BRAZIL - British researchers point out that large-scale contact between vaccinees and the Manaus variant may produce mutations capable of completely evading vaccine efficacy.
The current scenario in Brazil, which combines the start of vaccination with uncontrolled...
